Matches in Wikidata for { <http://www.wikidata.org/entity/Q74289022> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q74289022 description "artículu científicu espublizáu n'avientu de 1997" @default.
- Q74289022 description "im Dezember 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74289022 description "scientific article published on 01 December 1997" @default.
- Q74289022 description "wetenschappelijk artikel" @default.
- Q74289022 description "наукова стаття, опублікована в грудні 1997" @default.
- Q74289022 name "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 name "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 type Item @default.
- Q74289022 label "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 label "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 prefLabel "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 prefLabel "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 P1433 Q74289022-4DE97970-B842-4F9B-B8C5-964EFFA10D99 @default.
- Q74289022 P1476 Q74289022-17B106EE-3AAA-4B1F-B6C2-BF1739397D7D @default.
- Q74289022 P2093 Q74289022-5B87D000-E1F9-4A68-8939-07179019BF36 @default.
- Q74289022 P2093 Q74289022-7C49AAE4-6C1F-4270-B096-A2F3802321FC @default.
- Q74289022 P2093 Q74289022-854D4ADB-CC1C-4D5A-8EC8-BD953E0F9880 @default.
- Q74289022 P2093 Q74289022-960184D1-4074-4192-AD36-4A4B8C4B3CBF @default.
- Q74289022 P2093 Q74289022-A0503766-EC03-4784-AB46-32F958C1C25F @default.
- Q74289022 P2093 Q74289022-AD367A4B-BE8D-4341-B507-D5C60F002254 @default.
- Q74289022 P2093 Q74289022-DD6E0464-9A24-4589-94B5-E1FF2D6EAD39 @default.
- Q74289022 P304 Q74289022-6FFDDD85-F3AB-4256-A4D8-BA618EB04A6A @default.
- Q74289022 P31 Q74289022-CC16BA54-A6BF-41B6-8A5B-8F5516F3BE13 @default.
- Q74289022 P433 Q74289022-8A62F219-66C0-4093-A763-57A68A6ADFC2 @default.
- Q74289022 P478 Q74289022-1A22AC47-D8D7-42CE-9E4B-253403D07560 @default.
- Q74289022 P577 Q74289022-AF5B2F04-F386-4B8B-A320-0B180F7BBE52 @default.
- Q74289022 P698 Q74289022-C5A7C47D-0963-46F8-93C6-1E4855443572 @default.
- Q74289022 P921 Q74289022-34E9E7A7-6338-4B7F-A0BE-F0FC206E665B @default.
- Q74289022 P698 9494194 @default.
- Q74289022 P1433 Q15763772 @default.
- Q74289022 P1476 "[Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]" @default.
- Q74289022 P2093 "Esteban Fuertes M" @default.
- Q74289022 P2093 "Luengo Alpuente S" @default.
- Q74289022 P2093 "Ramírez Fernández JC" @default.
- Q74289022 P2093 "Resel Estévez L" @default.
- Q74289022 P2093 "Salinas Casado J" @default.
- Q74289022 P2093 "Salomon Moh'd S" @default.
- Q74289022 P2093 "Virseda Chamorro M" @default.
- Q74289022 P304 "1057-1066" @default.
- Q74289022 P31 Q13442814 @default.
- Q74289022 P433 "10" @default.
- Q74289022 P478 "50" @default.
- Q74289022 P577 "1997-12-01T00:00:00Z" @default.
- Q74289022 P698 "9494194" @default.
- Q74289022 P921 Q506659 @default.